Callos Andrew sold CYTK
July 1, 2026 · Form 4 insider transaction
Callos Andrew sold 15,000 shares of Cytokinetics, Incorporated at $85.80 per share, a transaction worth $1.29M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
15,000
Price
$85.80
Total value
$1.29M
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after58,555
OwnershipDirect
10b5-1 planNo
AmendedNo